1,413 results on '"Herrmann, Howard C"'
Search Results
2. Neutrophil‐to‐Lymphocyte Ratios in Patients Undergoing Aortic Valve Replacement: The PARTNER Trials and Registries
3. Patient-Prosthesis Mismatch After Surgical Aortic Valve Replacement: Analysis of the PARTNER Trials
4. Atrial Fibrillation Burden and Atrial Shunt Therapy in Heart Failure With Preserved Ejection Fraction
5. 2023 ACC/AHA/SCAI advanced training statement on interventional cardiology (coronary, peripheral vascular, and structural heart interventions): A report of the ACC Competency Management Committee
6. First-in-Human Multicenter Experience of the Newest Generation Supra-Annular Self-Expanding Evolut FX TAVR System
7. Very early infective endocarditis after transcatheter aortic valve replacement
8. Explant vs Redo-TAVR After Transcatheter Valve Failure: Mid-Term Outcomes From the EXPLANTORREDO-TAVR International Registry
9. Cardiology Assessment of Patients Undergoing Evaluation for Orthotopic Liver Transplantation
10. Sex Differences in Infective Endocarditis After Transcatheter Aortic Valve Replacement
11. Standardized Definitions for Bioprosthetic Valve Dysfunction Following Aortic or Mitral Valve Replacement: JACC State-of-the-Art Review
12. Bioprosthetic Aortic Valve Hemodynamics: Definitions, Outcomes, and Evidence Gaps: JACC State-of-the-Art Review
13. SCAI Publications Committee Manual of Standard Operating Procedures: 2022 Update
14. Economic Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Low Surgical Risk: Results from the PARTNER 3 Trial
15. Surgical Treatment of Patients With Infective Endocarditis After Transcatheter Aortic Valve Implantation
16. Infective Endocarditis Caused by Staphylococcus aureus After Transcatheter Aortic Valve Replacement
17. Rationale and design of the SMall Annuli Randomized To Evolut or SAPIEN Trial (SMART Trial)
18. Transcatheter Mitral Valve Therapy in the United States: A Report From the STS-ACC TVT Registry
19. The Clinical Implications of Body Surface Area as a Poor Proxy for Cardiac Output
20. Prosthesis-Patient Mismatch After Aortic Valve Replacement in the PARTNER 2 Trial and Registry
21. Impact of Echocardiographic Parameters on Recurrent Stroke in the Randomized REDUCE PFO Cryptogenic Stroke Trial
22. Stroke Complicating Infective Endocarditis After Transcatheter Aortic Valve Replacement
23. Preventing Coronary Obstruction During Transcatheter Aortic Valve Replacement: Results From the Multicenter International BASILICA Registry
24. Effect of Mitral Valve Gradient After MitraClip on Outcomes in Secondary Mitral Regurgitation: Results From the COAPT Trial
25. Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk
26. ICE-guided percutaneous non-coronary interventional procedures
27. Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease
28. STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement
29. Mitral Regurgitation in Low-Flow, Low-Gradient Aortic Stenosis Patients Undergoing TAVR: Insights From the TOPAS-TAVI Registry
30. Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years
31. Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Arteries
32. Health Status After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis
33. Left Ventricular Hypertrophy and Hypertrophic Cardiomyopathy in Adult Solid Organ Transplant Recipients
34. Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve Replacement
35. Self-Expanding Valve System for Treatment of Native Aortic Regurgitation by Transcatheter Aortic Valve Implantation (from the STS/ACC TVT Registry)
36. 3-Year Outcomes After Valve-in-Valve Transcatheter Aortic Valve Replacement for Degenerated Bioprostheses: The PARTNER 2 Registry
37. Prosthesis–Patient Mismatch in Patients Undergoing Transcatheter Aortic Valve Replacement: From the STS/ACC TVT Registry
38. Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER Trial
39. Lack of Association Between Percutaneous Coronary Intervention and Transcatheter Aortic Valve Replacement Outcomes in New York Hospitals
40. Enrollment of Older Patients, Women, and Racial and Ethnic Minority Individuals in Valvular Heart Disease Clinical Trials
41. LB-9 | Self-Expanding Versus Balloon-Expandable Transcatheter Aortic Valve Replacement in Patients with Small Aortic Annuli: Additional Outcomes from the SMART Trial
42. OR4-1 | In-hospital Results with Intravascular Lithotripsy in the Real-World: Outcomes from the ACC NCDR® CathPCI Registry®
43. The Effect of Post-Dilatation on Outcomes in the PARTNER 2 SAPIEN 3 Registry
44. Impact of Resting Heart Rate at 30 Days Following Transcatheter or Surgical Aortic Valve Replacement and Cardiovascular Outcomes: Insights from The PARTNER 2 Trial
45. Impact of Aortic Root Anatomy and Geometry on Paravalvular Leak in Transcatheter Aortic Valve Replacement With Extremely Large Annuli Using the Edwards SAPIEN 3 Valve
46. Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial
47. Transcatheter Aortic Valve Replacement in Patients With Low-Flow, Low-Gradient Aortic Stenosis: The TOPAS-TAVI Registry
48. Sex-Specific Outcomes of Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve: Insights From the PARTNER II S3 High-Risk and Intermediate-Risk Cohorts
49. 31 - Transcatheter tricuspid valve intervention
50. 30 - Transcatheter mitral valve intervention
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.